Table V.
Mean concentration of cortisol (ng/ml), prolactin (ng/ml) and growth hormone (μIU/ml) in serum from breast cancer patients at T2 and T3.
| T2 | |||||||
|
| |||||||
| Serum hormones | A Reflexology + SIS |
B Massage + SIS |
C SIS |
A vs. B vs. C f-test p-value |
A vs. B f-test p-value |
A vs. C f-test p-value |
B vs. C f-test p-value |
|
| |||||||
| Cortisol | 123.2±5.6 | 110.4±5.6 | 117.9±5.8 | 0.28 | 0.33 | 1.00 | 1.00 |
| Prolactin | 6.4±1.1 | 5.3±1.1 | 4.3±1.1 | 0.39 | 1.00 | 0.51 | 1.00 |
| Growth hormone | 2.6±0.5 | 1.5±0.5 | 2.5±0.5 | 0.25 | 0.40 | 1.00 | 0.50 |
| T3 | |||||||
|
| |||||||
| Cortisol | 131.7±6.3 | 117.8±6.1 | 122.5±6.3 | 0.29 | 0.36 | 0.91 | 1.00 |
| Prolactin | 6.3±0.9 | 4.4±0.9 | 4.7±0.9 | 0.27 | 0.39 | 0.61 | 1.00 |
| Growth hormone | 3.0±1.1 | 3.2±1.0 | 3.6±1.1 | 0.92 | 1.00 | 1.00 | 1.00 |
Values are estimated marginal mean ± SEM. Also shown are the results from the univariate analysis of variance. All values are adjusted for baseline.